DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,122 filers reported holding DANAHER CORPORATION in Q2 2024. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $7,496 | +0.1% | 30,000 | 0.0% | 2.69% | +53.3% |
| Q1 2024 | $7,492 | +29.5% | 30,000 | +20.0% | 1.76% | -27.3% |
| Q4 2023 | $5,784 | -15.2% | 25,000 | -9.1% | 2.42% | -29.9% |
| Q3 2023 | $6,823 | +13.7% | 27,500 | +10.0% | 3.45% | +145.7% |
| Q2 2023 | $6,000 | +19.0% | 25,000 | +25.0% | 1.40% | -35.3% |
| Q1 2023 | $5,041 | -5.0% | 20,000 | 0.0% | 2.17% | -13.2% |
| Q4 2022 | $5,308 | -99.9% | 20,000 | -20.0% | 2.50% | -30.4% |
| Q3 2022 | $6,457,000 | -2.0% | 25,000 | -3.8% | 3.59% | -4.2% |
| Q2 2022 | $6,592,000 | -18.3% | 26,000 | -5.5% | 3.75% | +12.5% |
| Q1 2022 | $8,067,000 | -1.9% | 27,500 | +10.0% | 3.33% | -5.5% |
| Q4 2021 | $8,225,000 | -9.9% | 25,000 | -16.7% | 3.52% | +61.5% |
| Q3 2021 | $9,133,000 | +13.4% | 30,000 | 0.0% | 2.18% | +38.8% |
| Q2 2021 | $8,051,000 | -4.6% | 30,000 | -20.0% | 1.57% | -48.9% |
| Q1 2021 | $8,441,000 | -5.0% | 37,500 | -6.2% | 3.08% | -15.0% |
| Q4 2020 | $8,886,000 | -8.3% | 40,000 | -11.1% | 3.62% | -13.1% |
| Q3 2020 | $9,690,000 | +20.2% | 45,000 | -43.8% | 4.17% | +56.0% |
| Q2 2020 | $8,062,000 | -20.8% | 80,000 | -30.4% | 2.67% | -33.5% |
| Q1 2020 | $10,178,000 | +32.6% | 115,000 | +130.0% | 4.02% | +41.0% |
| Q4 2019 | $7,674,000 | +18.1% | 50,000 | +11.1% | 2.85% | -13.1% |
| Q3 2019 | $6,499,000 | -9.1% | 45,000 | -10.0% | 3.28% | +89.8% |
| Q2 2019 | $7,146,000 | -9.8% | 50,000 | -16.7% | 1.73% | -40.8% |
| Q1 2019 | $7,921,000 | +70.7% | 60,000 | +33.3% | 2.92% | +16.7% |
| Q4 2018 | $4,640,000 | -1.7% | 45,000 | -18.2% | 2.50% | +55.8% |
| Q3 2017 | $4,718,000 | – | 55,000 | – | 1.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
| Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
| Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
| Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
| CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
| Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
| Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
| BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
| Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |